On Independence Day this year I said that UPEK "has now given up on" its efforts to merge with Authen Tec.
Authen Tec is Florida based, UPEK is a California company. They are both in the biometric identification market -- fingerprint recognition doodads and stuff.
But the merger will go forward. A friendly deal has been reached. This will be accomplished as an Authen Tec purchase of UPEK rather than, as once expected, the other way around.
The two firms have of late been adversaries in IP litigation. In May of this year, the Northern District for the District Court of California, in San Jose, issued this procedural ruling in that case. I haven't kept up with it since, but imagine that the new combined company won't continue suing itself.
Showing posts with label San Jose. Show all posts
Showing posts with label San Jose. Show all posts
Wednesday, September 8, 2010
Wednesday, December 17, 2008
Three brief items
1. Microchip Technology says that it has plans to wage a proxy battle for control of Atmel, and has announced seven nominees for the board of directors.
Atmel, a company headquartered in San Jose, Calif., manufactures microcontrollers, advanced logic, mixed-signal, nonvolatile memory and radio frequency (RF) components.
Microchip made an unsolicited bid to acquire Atmel in late October and was rebuffed. This week's announcement is in response.
2. RA Capital Healthcare Fund, a hedge fund with a biotech focus, is urging the board of Northstar Neuroscience Inc. to make a cash distribution to its shareholders or to implement a share buy-back program.
Northstar, based in Seattle, Wash., makes medical devices, especially a system that delivers targeted electrical impulses, "cortical stimulation," to the brain for what the company's website describes as "investigatory purposes."
RA Capital's letter is mostly limited to "urging" a course of action. There is no real "or else" clause because RA seems to be aware that it isn't in much of a position to forcefully re-direct corporate policy.
3. Whatever you might want to say about Marc Dreier, the lawyer who was caught impersonating a pension plan official last week, you can't argue with his timing. If one is going to be caught in stupid high-level criminality, one should make sure that it is squeezed between Gov. Blago's arrest on the one side and the follies d'Madoff on the other.
For those who have forgotten Dreier and thus aren't sure what I'm talking about ... well, that's the point. And here's a reminder.
Atmel, a company headquartered in San Jose, Calif., manufactures microcontrollers, advanced logic, mixed-signal, nonvolatile memory and radio frequency (RF) components.
Microchip made an unsolicited bid to acquire Atmel in late October and was rebuffed. This week's announcement is in response.
2. RA Capital Healthcare Fund, a hedge fund with a biotech focus, is urging the board of Northstar Neuroscience Inc. to make a cash distribution to its shareholders or to implement a share buy-back program.
Northstar, based in Seattle, Wash., makes medical devices, especially a system that delivers targeted electrical impulses, "cortical stimulation," to the brain for what the company's website describes as "investigatory purposes."
RA Capital's letter is mostly limited to "urging" a course of action. There is no real "or else" clause because RA seems to be aware that it isn't in much of a position to forcefully re-direct corporate policy.
3. Whatever you might want to say about Marc Dreier, the lawyer who was caught impersonating a pension plan official last week, you can't argue with his timing. If one is going to be caught in stupid high-level criminality, one should make sure that it is squeezed between Gov. Blago's arrest on the one side and the follies d'Madoff on the other.
For those who have forgotten Dreier and thus aren't sure what I'm talking about ... well, that's the point. And here's a reminder.
Subscribe to:
Posts (Atom)
